CME Group and Nasdaq recently announced a ten-year extension of CME Group’s exclusive license to offer futures and options on futures based on the Nasdaq-100 and other Nasdaq indexes, through 2029. The extended licensing agreement covers Nasdaq-100 futures and options, Nasdaq Biotechnology and Nasdaq Composite indexes, as well as other indexes that complement market participants’ U.S. index trading strategies.
As the world’s leading and most diverse derivatives marketplace, CME Group operates the largest equity index futures complex in the world. Nasdaq is a leading global provider of trading, clearing, exchange technology, listing, information and public company services.
This extension will allow both CME and Nasdaq to continue to innovate as partners within the equity index marketplace and deliver customer-focused risk management tools such as the Basis Trade at Index Close (BTIC) functionality on Nasdaq-100 futures, which enables market participants to execute a basis trade relative to the official close for the underlying index for more efficient cash management.
For more information please click on the above link.
